Cumberland Partners’s Idexx Laboratories IDXX Stock Holding History

Cumberland Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,750	Closed	-$1.15M	–	185
2025 Q1	$1.15M	Buy	+2,750	New	+$1.19M	0.09%	123

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cumberland Partners's IDXX Position: Q2 2025 in Review

Cumberland Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 2,750 shares — an estimated $1.15M sold.

Cumberland Partners first reported a position in IDXX in Q1 2025 and held it in 1 quarter. The position peaked at $1.15M in Q1 2025. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Cumberland Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
Cumberland Partners sold 2,750 Idexx Laboratories shares in Q2 2025, an estimated $1.15M.
Cumberland Partners first reported a position in Idexx Laboratories in Q1 2025 and held it in 1 quarter.
Cumberland Partners's Idexx Laboratories position peaked at $1.15M in Q1 2025.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Cumberland Partners's 13F filing for Q2 2025, filed 12 Aug 2025.